Search

Your search keyword '"Tortorella, Carla"' showing total 435 results

Search Constraints

Start Over You searched for: Author "Tortorella, Carla" Remove constraint Author: "Tortorella, Carla"
435 results on '"Tortorella, Carla"'

Search Results

1. Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project

6. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

8. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

12. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

13. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

14. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

16. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

17. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay

19. Brain reserve and timing of clinical onset in multiple sclerosis.

20. Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context.

22. Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.

25. Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis

27. Radiological Reporting Systems in Multiple Sclerosis.

28. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

29. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

30. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria

32. Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study

33. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

34. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

36. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

39. Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

40. Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose

41. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

42. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

43. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

44. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study

46. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

47. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

48. Stopping disease-modifying treatments in multiple sclerosis: a meta-analysis with meta-regression

49. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

50. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

Catalog

Books, media, physical & digital resources